Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Ribi

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 13, 2022
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccinesEva Pescosolido, Yannick D Muller, Marina Sabaté-Brescó, et al.
Arthritis and Rheumatism|February 2, 2008
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patientsCamillo Ribi, Pascal Cohen, Christian Pagnoux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusJusta Friebus-Kardash, Leonore Branco, Camillo Ribi, et al.
Frontiers in Immunology|January 28, 2022
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus ErythematosusJessica S Kleer, Pascal A Rabatscher, Jessica Weiss, et al.
Plos One|January 25, 2018
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosusSuzan Dahdal, Vasilios Devetzis, George Chalikias, et al.
Annals of the Rheumatic Diseases|January 29, 2022
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activityFrançois Chasset, Alexis Mathian, Karim Dorgham, et al.
Rheumatology (Oxford, England)|August 5, 2019
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosusHaïg Nigolian, Camillo Ribi, Delphine S Courvoisier, et al.
Revue Medicale Suisse|June 5, 2020
[Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment]Dimitri Arangalage, Anna Giulia Pavon, Sarah Hugelshofer, et al.
The Lancet. Oncology|January 8, 2019
New therapeutic perspectives to manage refractory immune checkpoint-related toxicitiesFilipe Martins, Gerasimos P Sykiotis, Michel Maillard, et al.
Genes|August 27, 2021
Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus ErythematosusSarah Kiener, Camillo Ribi, Irene Keller, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 13, 2022
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccinesEva Pescosolido, Yannick D Muller, Marina Sabaté-Brescó, et al.
Arthritis and Rheumatism|February 2, 2008
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patientsCamillo Ribi, Pascal Cohen, Christian Pagnoux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusJusta Friebus-Kardash, Leonore Branco, Camillo Ribi, et al.
Frontiers in Immunology|January 28, 2022
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus ErythematosusJessica S Kleer, Pascal A Rabatscher, Jessica Weiss, et al.
Plos One|January 25, 2018
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosusSuzan Dahdal, Vasilios Devetzis, George Chalikias, et al.
Annals of the Rheumatic Diseases|January 29, 2022
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activityFrançois Chasset, Alexis Mathian, Karim Dorgham, et al.
Rheumatology (Oxford, England)|August 5, 2019
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosusHaïg Nigolian, Camillo Ribi, Delphine S Courvoisier, et al.
Revue Medicale Suisse|June 5, 2020
[Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment]Dimitri Arangalage, Anna Giulia Pavon, Sarah Hugelshofer, et al.
The Lancet. Oncology|January 8, 2019
New therapeutic perspectives to manage refractory immune checkpoint-related toxicitiesFilipe Martins, Gerasimos P Sykiotis, Michel Maillard, et al.
Genes|August 27, 2021
Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus ErythematosusSarah Kiener, Camillo Ribi, Irene Keller, et al.
Pageof 13